223 related articles for article (PubMed ID: 9685926)
21. Polysaccharide matrices for microbially triggered drug delivery to the colon.
Sinha VR; Kumria R
Drug Dev Ind Pharm; 2004 Feb; 30(2):143-50. PubMed ID: 15089048
[TBL] [Abstract][Full Text] [Related]
22. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers.
Krishnaiah YS; Satyanarayana S; Rama Prasad YV; Narasimha Rao S
J Control Release; 1998 Nov; 55(2-3):245-52. PubMed ID: 9795074
[TBL] [Abstract][Full Text] [Related]
23. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
Krishnaiah YS; Karthikeyan RS; Satyanarayana V
Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
[TBL] [Abstract][Full Text] [Related]
24. In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery.
Tuğcu-Demiröz F; Acartürk F; Takka S; Konuş-Boyunağa O
J Drug Target; 2004 Feb; 12(2):105-12. PubMed ID: 15203904
[TBL] [Abstract][Full Text] [Related]
25. Low swelling, crosslinked guar and its potential use as colon-specific drug carrier.
Gliko-Kabir I; Yagen B; Penhasi A; Rubinstein A
Pharm Res; 1998 Jul; 15(7):1019-25. PubMed ID: 9688054
[TBL] [Abstract][Full Text] [Related]
26. Guar gum/ethylcellulose coated pellets for colon-specific drug delivery.
Ji CM; Xu HN; Sun NY; Lu YP; Wu W
Yao Xue Xue Bao; 2007 Jun; 42(6):656-62. PubMed ID: 17702405
[TBL] [Abstract][Full Text] [Related]
27. Guar gum as potential film coating material for colon-specific delivery of fluorouracil.
Ji CM; Xu HN; Wu W
J Biomater Appl; 2009 Jan; 23(4):311-29. PubMed ID: 18667456
[TBL] [Abstract][Full Text] [Related]
28. Budesonide-loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro/in vivo evaluation.
Liu Y; Zhou H
Int J Mol Sci; 2015 Jan; 16(2):2693-704. PubMed ID: 25629228
[TBL] [Abstract][Full Text] [Related]
29. Influence of natural polymer coating on novel colon targeting drug delivery system.
Ravi V; Siddaramaiah ; Pramod Kumar TM
J Mater Sci Mater Med; 2008 May; 19(5):2131-6. PubMed ID: 17999035
[TBL] [Abstract][Full Text] [Related]
30. Comparison of guar gum from different sources for the preparation of prolonged-release or colon-specific dosage forms.
Acartürk F; Celkan A
Pharm Dev Technol; 2009; 14(3):271-7. PubMed ID: 19519181
[TBL] [Abstract][Full Text] [Related]
31. Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping.
Kumar B; Kulanthaivel S; Mondal A; Mishra S; Banerjee B; Bhaumik A; Banerjee I; Giri S
Colloids Surf B Biointerfaces; 2017 Feb; 150():352-361. PubMed ID: 27847225
[TBL] [Abstract][Full Text] [Related]
32. Utilizing guar gum for development of "tabs in cap' system of losartan potassium for chronotherapeutics.
Gangwar G; Kumar A; Pathak K
Int J Biol Macromol; 2015 Jan; 72():812-8. PubMed ID: 25268456
[TBL] [Abstract][Full Text] [Related]
33. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets.
Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
Eur J Pharm Sci; 2003 Aug; 19(5):355-62. PubMed ID: 12907286
[TBL] [Abstract][Full Text] [Related]
34. Recent updates on guar gum derivatives in colon specific drug delivery.
Manna S; Karmakar S; Sen O; Sinha P; Jana S; Jana S
Carbohydr Polym; 2024 Jun; 334():122009. PubMed ID: 38553200
[TBL] [Abstract][Full Text] [Related]
35. Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer.
Chaurasia M; Chourasia MK; Jain NK; Jain A; Soni V; Gupta Y; Jain SK
AAPS PharmSciTech; 2006 Sep; 7(3):74. PubMed ID: 17025254
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.
Al-Saidan SM; Krishnaiah YS; Patro SS; Satyanaryana V
AAPS PharmSciTech; 2005 Jul; 6(1):E14-21. PubMed ID: 16353958
[TBL] [Abstract][Full Text] [Related]
37. The effect of dietary protein source and guar gum on gastrointestinal growth and enteroglucagon secretion in the rat.
Southon S; Gee JM; Johnson IT
Br J Nutr; 1987 Jul; 58(1):65-72. PubMed ID: 3040079
[TBL] [Abstract][Full Text] [Related]
38. Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation.
Kenyon CJ; Nardi RV; Wong D; Hooper G; Wilding IR; Friend DR
Aliment Pharmacol Ther; 1997 Feb; 11(1):205-13. PubMed ID: 9042995
[TBL] [Abstract][Full Text] [Related]
39. pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs.
George M; Abraham TE
Int J Pharm; 2007 Apr; 335(1-2):123-129. PubMed ID: 17147980
[TBL] [Abstract][Full Text] [Related]
40. Guar gum as a microbially degradable component for an oral colon delivery system based on a combination strategy: formulation and in vitro evaluation.
Moutaharrik S; Meroni G; Soggiu A; Foppoli A; Cerea M; Palugan L; Caloni F; Martino PA; Gazzaniga A; Maroni A
Drug Deliv Transl Res; 2024 Mar; 14(3):826-838. PubMed ID: 37824039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
